|
The call for volonteers to participate in the first part of the study of high dose intravenous vitamin C has started to appear in the local press of Montreal.
Breast cancer patients are not admissible in this study. It is restricted to lymphoma, or sarcoma or bladder or kidney cancer patients "that failed to respond, or is inappropriate for standard therapies".
Since this is a single site trial & in view of the required presence 3 times a week for the 90 minute IV's,only local residents will find it practical to participate.
Just in case this might nevertheless interest someone here is the place to call:
Dr. L.J. Hoffer MD,PhD
514-340-8222 extension 4572
|